Author: Hope

FDA Approves New Intravenous Monkeypox Drug Treatment From PFIZER-Linked SIGA Technologies

Pfizer is apparently at it again, conveniently hitting another grand slam with another perfectly timed drug release for the latest viral outbreak sweeping the west – monkeypox.

After hitting it out of the park with their experimental mRNA Covid vaccine – typically what would be considered a once-in-a-lifetime development that’s cashing the company out to a tune of $1,000 per second – it seems like a long stretch that Pfizer would be involved in the ‘cure’ for the new outbreak, but hey, they apparently pulled it off.

Read More

SUBSCRIBE TO THE HOPEGIRL BLOG

Sign up to have our latest blog posts delivered to your inbox! 

We respect your email privacy

Archives